EIBALL Session

EIBALL 14 - Quantitative imaging biomarkers in hybrid imaging

February 28, 12:30 - 13:30 CET

5 min
Chairperson's introduction
Clemens C. Cyran, München / Germany
15 min
Quantitative imaging biomarkers in nuclear medicine
Ronald Boellaard, Wilnis / Netherlands
  1. To become familiar with the rationale behind quality control and the history of EARL accreditation.  
  2. To become familiar with the process of accreditation.
  3. To understand the differences between EARL accreditation and QIBA conformance testing.
15 min
Clinical use of SUV in daily practice
Susan Notohamiprodjo, Munich / Germany
  1. To learn about study design for clinical validation of SUV.  
  2. To become familiar with clinical scenarios in which baseline SUVs are relevant for treatment allocation.
  3. To become familiar with clinical scenarios in which delta SUVs are relevant for treatment allocation.
15 min
On the horizon. Artificial intelligence (AI)-based whole-body (WB) PET imaging biomarkers: disruption or delusion?
Lalith Kumar Shiyam Sundar, Wien / Austria
  1. To learn about WB PET imaging biomarkers and the role of AI in deriving them.
  2. To understand the steps needed for implementation of AI to derive WB PET imaging biomarkers.
  3. To become familiar with potential and pitfalls of AI-derived WB PET biomarkers in clinical applications.
10 min
Panel discussion: What can be learned from the EARL accreditation programme and QIBA profile conformance testing?